Aptose Biosciences (APTO) PT Raised to $9 at RBC Capital

March 11, 2020 7:30 AM EDT
Get Alerts APTO Hot Sheet
Price: $1.71 --0%

Rating Summary:
    10 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
RBC Capital analyst Gregory Renza raised the price target on Aptose Biosciences (NASDAQ: APTO) to $9.00 (from $8.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change